GPT and liver disorder: The American Association for the Study of Liver Disease (AASLD) and the Asian Pacific Association for the Study of the Liver (APASL) guidelines recommend initiating antiviral treatment for patients with ALT > 2 times upper limit of normal (ULN) and elevated HBV DNA, whereas the European Association for the Study of the Liver (EASL) guideline is more liberal and recommends starting antiviral therapy in patients with ALT > ULN and elevated HBV DNA.